3
Views
4
CrossRef citations to date
0
Altmetric
Original Article

The Treatment of Low Differentiated Germinal Cancers of the Testis Using Mithramycin

&
Pages 100-104 | Received 01 Sep 1973, Published online: 15 Feb 2010

REFERENCES

  • Bakhaeva, G. P., Berlin, Y. A., Boldyreva, E. F., Chuprunova, O. A., Kolosov, M. N., Soifer, V. S., Vasiljeva, T. E. & Yartseva, I. V. 1968. The structure of aureolic acid (Mithramycin). Tetrahedron Lett 32, 3595–3598.
  • Brown, J. H. & Kennedy, B. J. 1965. Mithramycin in the treatment of disseminated testicular neoplasm. N Engl J Med 272, 111–118.
  • Currerie, A. F. & Ansfield, F. J. 1960. Mithramycin—human toxicology and preliminary therapeutic investigation. Cancer Chemother Rep 8, 18–22.
  • Ekman, H., Giertz, G., Jönsson, G. & Notter, G. 1965. Tumors of the testicle: a report from Sweden on combined surgico-radiotherapeutic treatment. XIII Congrès Soc Internat d'Urol II, 26–62.
  • Ingemansson, S., Henriksson, H. & Ling, L. 1972. Lymfadenectomi vid testistumörer. In Sammanfattningar av symposier och föredrag, XXIX Medicinska Riksstämman, Svenska Läkarsällskapet. Stockholm.
  • Javadpour, N., Thomas, W. & Burke, J. M. 1971. Production and treatment of testicular teratocarcinoma induced by genital ridge transplantation. J Urol 105, 534–539.
  • Johnson, D. E. & Luce, J. K. 1972. In Testicular Tumors (ed. D. E.Johnson), Chap. 9. p. 231. Huber; Bern, Stuttgart and Vienna.
  • Kennedy, B. J., Yarbro, J. W., Kickertz, V. & Sandberg-Wollheim, M. 1968. Effect of Mithramycin on mouse glioma. Cancer Res 28, 91–97.
  • Kennedy, B. J. 1970. Mithramycin therapy in advanced testicular neoplasms. Cancer 26, 755–766.
  • Kofmann, S. & Eisenstein, R. 1963. Mithramycin in the treatment of disseminated cancer. Cancer Chemother Rep 32, 77–96.
  • Koons, C. R., Sensenbrenner, L. L. & Owens, A. H., Jr. 1966. Clinical studies of Mithramycin in patients with embryonal cancer. Bull Johns Hopk Hosp 118, 462–475.
  • Li, M. C., Whitmore, W. F., Jr., Golbey, R. & Grabstad, H. 1960. Effects of combined drug therapy on metabolic cancer of the testis. JAMA 174, 1291–1299.
  • MacKenzie, A. R., Duruman, N. & Whitmore, W. F., Jr. 1967. Mithramycin in metastatic urogenital cancer. J Urol 98, 116–117.
  • Monto, R. W., Talley, R. W., Caldwell, M. J., Levin, W. E. & Guest, M. M. 1969. Observations on the mechanism of haemorrhagic toxicity in Mithramycin (NSC 24559) therapy. Cancer Res 29, 697–700.
  • Mount, B. M., Stevens, L. C. & Whitmore, W. F., Jr. 1970. The effect of chemotherapy on germinal testicular tumors in mice. Cancer 26, 570–576.
  • Parker, G. W., Wittsie, D. S. & Jackson, C. B., Jr. 1960. The clinical evaluation of PA-144 (Mithramycin) in solid tumors of adults. Cancer Chemother Rep 8, 23–26.
  • Rao, K. V., Cullen, W. P. & Sobin, B. A. 1960. Mithramycin: antibiotic with antitumor properties. Proc Amer Ass Cancer Res 3, 143.
  • Ream, N. W., Perlia, C. P., Wolter, J. & Taylor, S. G., III. 1968. Mithramycin therapy in disseminated germinal testicular cancer. JAMA 204, 96–102.
  • Stevens, L. C. 1964. Experimental production of testicular teratomas in mice. Proc Nat Acad Sci USA 52, 654–661.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.